276 related articles for article (PubMed ID: 25664849)
21. Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer.
Yu S; Wong YC; Wang XH; Ling MT; Ng CF; Chen S; Chan FL
Oncogene; 2008 May; 27(23):3313-28. PubMed ID: 18071305
[TBL] [Abstract][Full Text] [Related]
22. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
Chen M; Zhang J; Sampieri K; Clohessy JG; Mendez L; Gonzalez-Billalabeitia E; Liu XS; Lee YR; Fung J; Katon JM; Menon AV; Webster KA; Ng C; Palumbieri MD; Diolombi MS; Breitkopf SB; Teruya-Feldstein J; Signoretti S; Bronson RT; Asara JM; Castillo-Martin M; Cordon-Cardo C; Pandolfi PP
Nat Genet; 2018 Feb; 50(2):206-218. PubMed ID: 29335545
[TBL] [Abstract][Full Text] [Related]
23. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
[TBL] [Abstract][Full Text] [Related]
24. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
[TBL] [Abstract][Full Text] [Related]
25. The Drg-1 gene suppresses tumor metastasis in prostate cancer.
Bandyopadhyay S; Pai SK; Gross SC; Hirota S; Hosobe S; Miura K; Saito K; Commes T; Hayashi S; Watabe M; Watabe K
Cancer Res; 2003 Apr; 63(8):1731-6. PubMed ID: 12702552
[TBL] [Abstract][Full Text] [Related]
26. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
[TBL] [Abstract][Full Text] [Related]
27. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
28. [Androgens and increased lipogenesis in prostate cancer. Cell biologic and clinical perspectives].
Verhoeven G
Verh K Acad Geneeskd Belg; 2002; 64(3):189-95; discussion 195-6. PubMed ID: 12238242
[TBL] [Abstract][Full Text] [Related]
29. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
30. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
Shah YM; Rowan BG
Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
[TBL] [Abstract][Full Text] [Related]
31. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
[TBL] [Abstract][Full Text] [Related]
32. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
33. PGC1α drives a metabolic block on prostate cancer progression.
Wallace M; Metallo CM
Nat Cell Biol; 2016 May; 18(6):589-90. PubMed ID: 27230528
[TBL] [Abstract][Full Text] [Related]
34. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
Amorino GP; Deeble PD; Parsons SJ
Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
36. Targeting mitochondrial oxidative metabolism in melanoma causes metabolic compensation through glucose and glutamine utilization.
Lim JH; Luo C; Vazquez F; Puigserver P
Cancer Res; 2014 Jul; 74(13):3535-45. PubMed ID: 24812272
[TBL] [Abstract][Full Text] [Related]
37. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
39. TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.
Moreira D; Zhang Q; Hossain DM; Nechaev S; Li H; Kowolik CM; D'Apuzzo M; Forman S; Jones J; Pal SK; Kortylewski M
Oncotarget; 2015 Jul; 6(19):17302-13. PubMed ID: 26046794
[TBL] [Abstract][Full Text] [Related]
40. Steroid receptor coactivator 1 is an integrator of glucose and NAD+/NADH homeostasis.
Motamed M; Rajapakshe KI; Hartig SM; Coarfa C; Moses RE; Lonard DM; O'Malley BW
Mol Endocrinol; 2014 Mar; 28(3):395-405. PubMed ID: 24438340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
